TBXT and cancer: The functional pathway analysis of 94 DEGs, depicted in Figure S3D and Table S3 revealed significant enrichment in pathways such as “T cell receptor signaling pathway,” “PD‐L1 expression and PD‐1 checkpoint pathway in cancer,” and “primary immunodeficiency.”